Generic Tamiflu in India
{{date|January 13, 2006}}

{{w|Tamiflu}} (generic name: Oseltamivir) a common antiviral drug used in the treatment and prophylaxis of both Influenza virus A and Influenza virus B, will be marketed in a generic form in [[India]]. It is a prodrug, which is hydrolysed hepatically to the active metabolite, the free carboxylate of oseltamivir. It was developed by Gilead Sciences and is currently marketed by Hoffmann-La Roche (Roche) under the trade name Tamiflu.

Cipla received marketing approval from the drug controller-general of India and will launch a generic version of  Oseltamivir, Anti-Flu, in the domestic market this month. The drug will be priced at about Rs 1,000 per strip of 10  75 mg tablets, which is less than half the current Tamiflu market price of $60. The required dosage is two tablets every day during five days.

==Sources==

*{{source
|url=http://www.tamiflu.com/
|title=Roche Tamiflu
|author=Roche
|pub=oseltamivir
|date=January 13, 2006}}

*{{source
|url=http://en.wikipedia.org/wiki/Tamiflu
|title=Oseltamivir
|author=Wikipedia contributors
|pub=Wikipedia, The Free Encyclopedia
|date=January 13, 2006}}

*{{source
|url=http://www.fda.gov/cder/consumerinfo/druginfo/tamiflu.htm
|title=Tamiflu Consumer Information
|author=
|pub=FDA
|date=January 13, 2006}}

*{{source
|url=http://www.finegenerics.com/oseltamivir.html
|title=Tamiflu Drug Information
|author=Finegenerics
|pub=Tamiflu
|date=January 13, 2006}}

{{publish}}
{{archive}}
[[Category:India|India]]
[[Category:Asia]]
[[Category:Health]]
[[Category:Economy and business]]
[[Category:Disease]]
[[Category:Infectious disease]]
[[Category:Influenza]]
[[Category:Oseltamivir]]
(generic  Oseltamivir) a common antiviral drug used in the treatment and prophylaxis of both Influenza virus A and Influenza virus B, will be marketed in a generic form in India. It is a prodrug, which is hydrolysed hepatically to the active metabolite, the free carboxylate of oseltamivir. It was developed by Gilead Sciences and is currently marketed by Hoffmann-La Roche (Roche) under the trade name Tamiflu.

Cipla received marketing approval from the drug controller-general of India and will launch a generic version of  Oseltamivir, Anti-Flu, in the domestic market this month. The drug will be priced at about Rs 1,000 per strip of 10  75 mg tablets, which is less than half the current Tamiflu market price of $60. The required dosage is two tablets every day during five days.

*

*

*
India|India Asia Health Economy and business Disease Infectious disease Influenza Oseltamivir